SCHEMBL20173793

SCHEMBL20173793

CC(C)N1CCc2cc(C(=O)O)ccc2C1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
AKR1C3 P42330 6/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC8 Q9BY41 1/20 0.43
HRH3 Q9Y5N1 4/20 0.43
MYC P01106 1/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
AKR1C1 Q04828 2/20 0.41
RARB P10826 1/20 0.40
PTGER1 P34995 1/20 0.40
KCNH2 Q12809 1/20 0.40
SRD5A2 P31213 2/20 0.40
SRD5A1 P18405 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15142204 0.94 ALDH1A1 (0.51) ALDH1A1AKR1C3HRH3MYCKDM4E
SCHEMBL15142217 0.87 ALDH1A1 (0.49) ALDH1A1AKR1C3HDAC6HDAC8HRH3
SCHEMBL26167813 0.87 PTGER1 (0.44) ALDH1A1HDAC6HDAC8HRH3KDM4E
SCHEMBL13791770 0.87 HDAC6 (0.42) ALDH1A1HDAC6HDAC8HRH3KDM4E
SCHEMBL26161462 0.87 HSD17B3 (0.51) ALDH1A1AKR1C3HDAC6HDAC8HRH3
Hydrochloric Acid SCHEMBL3880242 0.85 PTGER1 (0.43) ALDH1A1HDAC6HDAC8HRH3KDM4E
SCHEMBL3885726 0.85 OGA (0.46) ALDH1A1AKR1C3HDAC6KDM4ELMNA
SCHEMBL3879495 0.84 ACACB (0.54) ALDH1A1HDAC6HDAC8HRH3KDM4E
SCHEMBL25873240 0.83 POLB (0.50) ALDH1A1HDAC6HDAC8HRH3PTGER1
SCHEMBL4520343 0.82 HRH3 (0.55) ALDH1A1HRH3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2020-03-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885AKR1C3 1156/4885HDAC6 597/4885
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885AKR1C3 1156/4885HDAC6 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.